Literature DB >> 33548624

Segmental structural dynamics in Aβ42 globulomers.

Allison Yoon1, James Zhen1, Zhefeng Guo2.   

Abstract

Aβ42 aggregation plays a central role in the pathogenesis of Alzheimer's disease. In addition to the insoluble fibrils that comprise the amyloid plaques, Aβ42 also forms soluble aggregates collectively called oligomers, which are more toxic and pathogenic than fibrils. Understanding the structure and dynamics of Aβ42 oligomers is critical for developing effective therapeutic interventions against these oligomers. Here we studied the structural dynamics of Aβ42 globulomers, a type of Aβ42 oligomers prepared in the presence of sodium dodecyl sulfate, using site-directed spin labeling. Spin labels were introduced, one at a time, at all 42 residue positions of Aβ42 sequence. Electron paramagnetic resonance spectra of spin-labeled samples reveal four structural segments based on site-dependent spin label mobility pattern. Segment-1 consists of residues 1-6, which have the highest mobility that is consistent with complete disorder. Segment-3 is the most immobilized region, including residues 31-34. Segment-2 and -4 have intermediate mobility and are composed of residues 7-30 and 35-42, respectively. Considering the inverse relationship between protein dynamics and stability, our results suggest that residues 31-34 are the most stable segment in Aβ42 oligomers. At the same time, the EPR spectral lineshape suggests that Aβ42 globulomers lack a well-packed structural core akin to that of globular proteins.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid; Aβ42 oligomers; Neurodegenerative diseases; Protein aggregation

Mesh:

Substances:

Year:  2021        PMID: 33548624      PMCID: PMC7904658          DOI: 10.1016/j.bbrc.2021.01.081

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  43 in total

1.  Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis.

Authors:  Rakez Kayed; Elizabeth Head; Jennifer L Thompson; Theresa M McIntire; Saskia C Milton; Carl W Cotman; Charles G Glabe
Journal:  Science       Date:  2003-04-18       Impact factor: 47.728

Review 2.  The toxic Aβ oligomer and Alzheimer's disease: an emperor in need of clothes.

Authors:  Iryna Benilova; Eric Karran; Bart De Strooper
Journal:  Nat Neurosci       Date:  2012-01-29       Impact factor: 24.884

3.  Amyloid-beta(1-42) rapidly forms protofibrils and oligomers by distinct pathways in low concentrations of sodium dodecylsulfate.

Authors:  Vijayaraghavan Rangachari; Brenda D Moore; Dana Kim Reed; Leilani K Sonoda; Alexander W Bridges; Erin Conboy; David Hartigan; Terrone L Rosenberry
Journal:  Biochemistry       Date:  2007-10-02       Impact factor: 3.162

4.  Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents.

Authors:  Volker Nimmrich; Christiane Grimm; Andreas Draguhn; Stefan Barghorn; Alexander Lehmann; Hans Schoemaker; Heinz Hillen; Gerhard Gross; Ulrich Ebert; Claus Bruehl
Journal:  J Neurosci       Date:  2008-01-23       Impact factor: 6.167

5.  Stable activity of a deubiquitylating enzyme (Usp2-cc) in the presence of high concentrations of urea and its application to purify aggregation-prone peptides.

Authors:  Mohammad Shahnawaz; Arjun Thapa; Il-Seon Park
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

6.  Structural characterization of a soluble amyloid beta-peptide oligomer.

Authors:  Liping Yu; Rohinton Edalji; John E Harlan; Thomas F Holzman; Ana Pereda Lopez; Boris Labkovsky; Heinz Hillen; Stefan Barghorn; Ulrich Ebert; Paul L Richardson; Laura Miesbauer; Larry Solomon; Diane Bartley; Karl Walter; Robert W Johnson; Philip J Hajduk; Edward T Olejniczak
Journal:  Biochemistry       Date:  2009-03-10       Impact factor: 3.162

7.  Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils.

Authors:  Michael T Colvin; Robert Silvers; Qing Zhe Ni; Thach V Can; Ivan Sergeyev; Melanie Rosay; Kevin J Donovan; Brian Michael; Joseph Wall; Sara Linse; Robert G Griffin
Journal:  J Am Chem Soc       Date:  2016-07-14       Impact factor: 15.419

8.  Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies.

Authors:  Heinz Hillen; Stefan Barghorn; Andreas Striebinger; Boris Labkovsky; Reinhold Müller; Volker Nimmrich; Marc W Nolte; Claudia Perez-Cruz; Ingrid van der Auwera; Fred van Leuven; Marcel van Gaalen; Anton Y Bespalov; Hans Schoemaker; James P Sullivan; Ulrich Ebert
Journal:  J Neurosci       Date:  2010-08-04       Impact factor: 6.167

Review 9.  Technological advances in site-directed spin labeling of proteins.

Authors:  Wayne L Hubbell; Carlos J López; Christian Altenbach; Zhongyu Yang
Journal:  Curr Opin Struct Biol       Date:  2013-07-11       Impact factor: 6.809

10.  Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice.

Authors:  Anne Eckert; Susanne Hauptmann; Isabel Scherping; Jessica Meinhardt; Virginie Rhein; Stefan Dröse; Ulrich Brandt; Marcus Fändrich; Walter E Müller; Jürgen Götz
Journal:  J Mol Med (Berl)       Date:  2008-08-16       Impact factor: 4.599

View more
  2 in total

1.  Lipid membranes induce structural conversion from amyloid oligomers to fibrils.

Authors:  Lei Gu; Zhefeng Guo
Journal:  Biochem Biophys Res Commun       Date:  2021-04-14       Impact factor: 3.322

2.  Amyloid-beta peptide (25-35) triggers a reorganization of lipid membranes driven by temperature changes.

Authors:  Oleksandr Ivankov; Tatiana N Murugova; Elena V Ermakova; Tomáš Kondela; Dina R Badreeva; Pavol Hrubovčák; Dmitry Soloviov; Alexey Tsarenko; Andrey Rogachev; Alexander I Kuklin; Norbert Kučerka
Journal:  Sci Rep       Date:  2021-11-09       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.